BioWorld

Jan. 21, 2019

View Archived Issues

Money raised by biotech: 2019 vs. 2018

Read More

Biopharma money raised: Jan. 1 - 17, 2019

Read More

Week in review

Read More

Week in Washington

Read More

Word on the street

Read More

Conference data: December 2018

Read More

Regulatory submissions, approvals and other actions: December 2018

Read More

Handing over the dealmaking torch, 2018 logs monster biopharma deals, paves the way for top M&As

Biopharma licensing deals signed in 2018 climbed to 1,364 and have a projected value of $119.54 billion, a four-year high for an industry still riding the immuno-oncology wave. Read More

The week's biggest gainers and losers

Read More

BioWorld stock report for public biotechnology companies

Read More